Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Lecture is given every year by an established investigator in the field of cardiac metabolism at the Society for Heart and Vascular Metabolism conference in honour of the Society's founding father.

On Wednesday 26 June 2019, Professor Kieran Clarke delivered the annual "William C. Stanley" Award Lecture entitled Exogenus ketones for the Heart? at the 17th Annual Society for Heart and Vascular Metabolism Conference in Amsterdam. The Lecture is delivered each year in honour of William C. Stanley, the founding father of the SHVM, who passed away in 2013. The theme of this year's conference was targeting metabolic pathways to treat cardiovascular diseases.

In the past few years, a number of human and animal studies have suggested that an increase in ketone metabolism may benefit the failing heart. In her talk, Professor Clarke discussed the ketone bodies, d-β-hydroxybutyrate and acetoacetate, which are not found in large amounts in the human diet, but are produced in the liver from free fatty acids as an alternative energy supply for the brain, heart and skeletal muscle, in response to low blood glucose and insulin levels caused by fasting or a ketogenic diet.

In 2003, Professor Clarke and her team invented a new food group based on ketone metabolism, a ketone ester that they called ΔG®. As the ester is broken down slowly in the gut, it directly raises circulating d-β-hydroxybutyrate levels, overcoming the need for fasting or a ketogenic diet. A single ΔG® drink can raise circulating ketone levels to those found after several days of fasting or a ketogenic diet, and levels remain elevated for several hours following a drink. Professor Clarke's team have run many human studies of ΔG®. Their study in patients with type 2 diabetes found that three ΔG® drinks a day for five days normalised fast blood glucose, triglycerides and cholesterol levels. Her lecture also outlined the story of how ΔG®  developed to the point at which they have scaled up production to many tons for sale in the US.

 

Earlier in the conference, on Tuesday 25 June, Matthew Kerr, BHF DPhil student in the Heather Group, was awarded the William C. Stanley Early Investigator Award, which is given in honour of the founder's priority towards the support and mentoring of early investigators. Matthew delivered a talk entitled Energetic dysfunction in the type 2 diabetic myocardium is rescued by the deacetylase activator honokiol.

Earlier that day, Matthew's supervisor, Associate Professor Lisa Heather took part in a session tackling metabolic targets to combat cardiac IR injury, delivering a talk entitled Targeting metabolism to reduce cardiac IR injury in diabetes.

 

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations are in order for Professor Gero Miesenböck, who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Mootaz Salman receives prestigious science award from Iraq

Congratulations are in order for Dr Mootaz Salman, who has received the National Medal of Distinctive Scientific Achievement by the Government of Iraq.

Professor Denis Noble awarded the Lomonosov Gold Medal

The Russian Academy of Sciences has awarded its highest accolade, the Lomonosov Gold Medal, to Emeritus Professor Denis Noble CBE, FRS.

Professor Dame Frances Ashcroft awarded the Manpei Suzuki International Prize for Diabetes Research

The 2022 Manpei Suzuki International Prize for Diabetes Research recognises original and excellent achievements in diabetes research. Professor Ashcroft is the first women to win in the 15 years this prestigious Prize has been awarded.